shopping cart Your cart is empty
  • Home
  • Pharmaceutical
  • Advanced Drug Delivery System Market By Administration Route (Oral Drug Delivery, Pulmonary Drug Delivery, Injectable Drug Deliver...

Advanced Drug Delivery System Market By Administration Route (Oral Drug Delivery, Pulmonary Drug Delivery, Injectable Drug Delivery, Ocular Drug Delivery, Nasal Drug Delivery, Topical Drug Delivery, Implementable Drug Delivery, Transmucosal Drug Delivery), By End Users (Hospitals, Home Care Settings, Ambulatory Surgical Centers, Diagnostic Centers), Industry Size, Growth, Share And Forecast To 2022

Published By: Brisk Insights | Published On: Apr 22, 2016

Key Findings


The Global Market and technologies for advanced drug delivery system is expected to grow at the CAGR of 7.6% during 2015-2022.The drivers which helps to increase the market are increasing chronic diseases in human beings, rising biologics market and advancement of drug innovation and technology. The major factors driving the market is increasing chronic diseases in human beings. The chronic disease are a long term despises whose precautions are taken very long. For example heart disease, diabetes, stroke, and chronic respiratory problems


Market Segment Insight


The market is majorly segmented on the basis of administration route and end users. On the basis of administration route the market is further sub segmented in tooral drug delivery and is further sub-segmented into solid, liquid and semi-solid, pulmonary drug delivery and is further sub segmented into metered dose inhalers, Dry powder inhalers and Nebulizer, Injectable drug delivery is further sub segmented into Devices of Injectable, Formation of Injectable,Ocular drug delivery is further sub segmented into Liquid Ocular,Solid Ocular and Semi-solid Ocular,Nasal drug delivery is further sub segmented into drops, sprays, powder, gels,Topical drug delivery is further sub segmented into Liquid, Solid, Semi-solid and Transdermal, Implementable drug delivery is further sub segmented into Active and Passive, Transmucosal drug delivery is further sub segmented into Oral and Other on the basis of end users the market is further sub-segmented into Hospitals, Home Care Settings, Ambulatory Surgical centers, Diagnostic Centers, Other end users


Regional Insight


Region wise the Asia pacific is the leading market in the advanced drug delivery system. Due to increasing population and increasing chronic disease accelerated the advanced drug delivery system of Asia pacific. North America is the second largest market for advanced drug delivery system and have a rapid growth rate.


Competitive Insights


Some of the major market players areAlbemarle corporation,BASF SE, Bayer AG,, and Clariant AGetc. Acquisitions, mergers and expansions are the key strategies adopted by the market players to sustain in the market.

CHAP 1. METHODOLOGY & SCOPE 11
1.1. RESEARCH METHODOLOGY 11
1.2. RESEARCH SCOPE & ASSUMPTIONS 11
1.3. LIST OF DATA SOURCES 11


CHAP 2. EXECUTIVE SUMMARY 12
2.1. GLOBAL ADVANCED DRUG DELIVERY SYSTEM SUMMARY & KEY BUYING CRITERIA 12
2.2. GLOBAL ADVANCED DRUG DELIVERY SYSTEM OUTLOOK 12
2.3. MARKET SEGMENTATION ANALYSIS 12
2.4. MARKET SIZE AND GROWTH PROSPECTS 2012-2022 12
2.5. GLOBAL ADVANCED DRUG DELIVERY SYSTEM VALUE CHAIN ANALYSIS 12
2.6. VENDOR LANDSCAPE 12


CHAP 3. GLOBAL MARKETS AND TECHNOLOGIES FOR ADVANCED DRUG DELIVERY SYSTEMS DETERMINENTS 13
3.1. MARKET DRIVER ANALYSIS 13
3.2. MARKET RESTRAINT ANALYSIS 13
3.3. KEY OPPORTUNITIES 13
3.4. CHALLENGES 13


CHAP 4. INDUSTRY ANALYSIS 14
4.1. GLOBAL ADVANCED DRUG DELIVERY SYSTEM – PORTER’S FIVE FORCE MODEL 14
4.2. GLOBAL ADVANCED DRUG DELIVERY SYSTEM – PESTEL ANALYSIS 14
4.3. GLOBAL ADVANCED DRUG DELIVERY SYSTEM – GAP ANALYSIS 14


CHAP 5. GLOBAL MARKETS AND TECHNOLOGIES FOR ADVANCED DRUG DELIVERY SYSTEMS BY ADMINISTRATION ROUTE, 2012-2022 ($ BILLION) 15
5.1. GLOBAL DRUG DELIVERY TECHNOLOGY MARKET BY ORAL DRUG DELIVERY 16
5.2. GLOBAL DRUG DELIVERY TECHNOLOGY MARKET BY PULMONARY DRUG DELIVERY 16
5.3. GLOBAL DRUG DELIVERY TECHNOLOGY MARKET BY INJECTABLE DRUG DELIVERY 16
5.4. GLOBAL DRUG DELIVERY TECHNOLOGY MARKET BY OCULAR DRUG DELIVERY 16
5.5. GLOBAL DRUG DELIVERY TECHNOLOGY MARKET BY NASAL DRUG DELIVERY 17
5.6. GLOBAL DRUG DELIVERY TECHNOLOGY MARKET BY TOPICAL DRUG DELIVERY 17
5.7. GLOBAL DRUG DELIVERY TECHNOLOGY MARKET BY IMPLEMENTABLE DRUG DELIVERY 17
5.8. GLOBAL DRUG DELIVERY TECHNOLOGY MARKET BY TRANSMUCOSAL DRUG DELIVERY 18


CHAP 6. GLOBAL MARKETS AND TECHNOLOGIES FOR ADVANCED DRUG DELIVERY SYSTEMS BY END USERS 2012-2022 ($ BILLION) 19
6.1. GLOBAL DRUG DELIVERY TECHNOLOGY MARKET BY HOSPITALS 19
6.2. GLOBAL DRUG DELIVERY TECHNOLOGY MARKET BY HOME CARE SETTINGS 19
6.3. GLOBAL DRUG DELIVERY TECHNOLOGY MARKET BY AMBULATORY SURGICAL CENTERS 19
6.4. GLOBAL DRUG DELIVERY TECHNOLOGY MARKET BY DIAGNOSTIC CENTERS 19
6.5. GLOBAL DRUG DELIVERY TECHNOLOGY MARKET BY OTHER END USERS 19


CHAP 7. GLOBAL MARKETS AND TECHNOLOGIES FOR ADVANCED DRUG DELIVERY SYSTEMS , REGIONAL OUTLOOK 2012-2022 ($ BILLION) 20
7.1. GLOBAL ADVANCED DRUG DELIVERY SYSTEM BY REGION 2012-2022 ($ BILLION) 20
7.2. NORTH AMERICA 20
7.2.1. NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 20
7.2.2. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ BILLION) 20
7.2.3. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 20
7.2.3.1. U.S. 20
7.2.3.1.1. U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 20
7.2.3.1.2. U.S. MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 20
7.2.3.2. CANADA 20
7.2.3.2.1. CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 20
7.2.3.2.2. CANADA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 20
7.3. EUROPE 20
7.3.1. EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 20
7.3.2. EUROPE MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ BILLION) 20
7.3.3. EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 20
7.3.3.1. GERMANY 20
7.3.3.1.1. GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 21
7.3.3.1.2. GERMANY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 21
7.3.3.2. UK 21
7.3.3.2.1. UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 21
7.3.3.2.2. UK MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 21
7.3.3.3. FRANCE 21
7.3.3.3.1. FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 21
7.3.3.3.2. FRANCE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 21
7.3.3.4. SPAIN 21
7.3.3.4.1. SPAIN MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 21
7.3.3.4.2. SPAIN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 21
7.3.3.5. REST OF EUROPE 21
7.3.3.5.1. RUSSIA MARKET ESTIMATES AND FORECAST2012-2022($BILLION) 22
7.3.3.5.2. OTHERS MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($BILLION) 22
7.4. ASIA PACIFIC 22
7.4.1. ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 22
7.4.2. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ BILLION) 22
7.4.3. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 22
7.4.3.1. CHINA 22
7.4.3.1.1. CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 22
7.4.3.1.2. CHINA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 22
7.4.3.2. INDIA 22
7.4.3.2.1. INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 22
7.4.3.2.2. INDIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 22
7.4.3.3. JAPAN 22
7.4.3.3.1. JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 22
7.4.3.3.2. JAPAN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($BILLION) 22
7.4.3.4. OTHERS 22
7.4.3.4.1. OTHER MARKET ESTIMATES AND FORECASTS 2012-2022($BILLION) 23
7.4.3.4.2. OTHER MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($BILLION) 23
7.5. MIDDLE EAST & AFRICA 23
7.5.1. MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 23
7.5.2. MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 23
7.6. LATIN AMERICA 23
7.6.1. LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 23
7.6.2. LATIN AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 23
7.6.2.1. BRAZIL 23
7.6.2.1.1. BRAZIL MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 23
7.6.2.1.2. BRAZIL MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 23


CHAP 8. COMPETITIVE LANDSCAPE 24
8.1. BAYER AG 25
8.1.1. COMPANY OVERVIEW 25
8.1.2. SCOT ANALYSIS 25
8.1.3. PRODUCT BENCHMARKING 25
8.1.4. STRATEGIC INITIATIVES 25
8.2. JOHNSON & JOHNSON SERVICES, INC. 25
8.2.1. COMPANY OVERVIEW 25
8.2.2. SCOT ANALYSIS 25
8.2.3. PRODUCT BENCHMARKING 25
8.2.4. STRATEGIC INITIATIVES 25
8.3. NOVARTIS AG 25
8.3.1. COMPANY OVERVIEW 25
8.3.2. SCOT ANALYSIS 25
8.3.3. PRODUCT BENCHMARKING 25
8.3.4. STRATEGIC INITIATIVES 25
8.4. PFIZER, INC. 25
8.4.1. COMPANY OVERVIEW 25
8.4.2. SCOT ANALYSIS 25
8.4.3. PRODUCT BENCHMARKING 25
8.4.4. STRATEGIC INITIATIVES 25
8.5. F. HOFFMANN-LA ROCHE LTD. 25
8.5.1. COMPANY OVERVIEW 25
8.5.2. SCOT ANALYSIS 25
8.5.3. PRODUCT BENCHMARKING 25
8.5.4. STRATEGIC INITIATIVES 25
8.6. 3M COMPANY 25
8.6.1. COMPANY OVERVIEW 25
8.6.2. SCOT ANALYSIS 26
8.6.3. PRODUCT BENCHMARKING 26
8.6.4. STRATEGIC INITIATIVES 26
8.7. ANTARES PHARMA, INC. 26
8.7.1. COMPANY OVERVIEW 26
8.7.2. SCOT ANALYSIS 26
8.7.3. PRODUCT BENCHMARKING 26
8.7.4. STRATEGIC INITIATIVES 26
8.8. GLAXOSMITHKLINE PLC 26
8.8.1. COMPANY OVERVIEW 26
8.8.2. SCOT ANALYSIS 26
8.8.3. PRODUCT BENCHMARKING 26
8.8.4. STRATEGIC INITIATIVES 26
8.9. SANOFI 26
8.9.1. COMPANY OVERVIEW 26
8.9.2. SCOT ANALYSIS 26
8.9.3. PRODUCT BENCHMARKING 26
8.9.4. STRATEGIC INITIATIVES 26
8.10. MERCK & CO., INC. 26
8.10.1. COMPANY OVERVIEW 26
8.10.2. SCOT ANALYSIS 26
8.10.3. PRODUCT BENCHMARKING 26
8.10.4. STRATEGIC INITIATIVES 26

TABLE 1 GLOBAL MARKETS AND TECHNOLOGIES FOR ADVANCED DRUG DELIVERY SYSTEMS BY ADMINISTRATION ROUTE, 2012-2022 ($ BILLION) 27
TABLE 2 GLOBAL DRUG DELIVERY TECHNOLOGY MARKET BY ORAL DRUG DELIVERY 27
TABLE 3 GLOBAL DRUG DELIVERY TECHNOLOGY MARKET BY SOLID ORAL DRUG DELIVERY 27
TABLE 4 GLOBAL DRUG DELIVERY TECHNOLOGY MARKET BY LIQUID ORAL DRUG DELIVERY 27
TABLE 5 GLOBAL DRUG DELIVERY TECHNOLOGY MARKET BY SEMI-SOLID ORAL DRUG DELIVERY 27
TABLE 6 GLOBAL DRUG DELIVERY TECHNOLOGY MARKET BY PULMONARY DRUG DELIVERY 27
TABLE 7 GLOBAL DRUG DELIVERY TECHNOLOGY MARKET BY METERED DOSE INHALERS DRUG DELIVERY 27
TABLE 8 GLOBAL DRUG DELIVERY TECHNOLOGY MARKET BY DRY POWDER INHELER DRUG DELIVERY 27
TABLE 9 GLOBAL DRUG DELIVERY TECHNOLOGY MARKET BY NEBULIZER DRUG DELIVERY 27
TABLE 10 GLOBAL DRUG DELIVERY TECHNOLOGY MARKET BY INJECTABLE DRUG DELIVERY 27
TABLE 11 GLOBAL DRUG DELIVERY TECHNOLOGY MARKET BY DEVICES OF INJECTABLE DRUG DELIVERY 27
TABLE 12 GLOBAL DRUG DELIVERY TECHNOLOGY MARKET BY FORMULATION OF INJECTABLE DRUG DELIVERY 27
TABLE 13 GLOBAL DRUG DELIVERY TECHNOLOGY MARKET BY OCULAR DRUG DELIVERY 27
TABLE 14 DRUG DELIVERY TECHNOLOGY MARKET BY OCULAR DRUG DELIVERY 27
TABLE 15 DRUG DELIVERY TECHNOLOGY MARKET BY LIQUID OCULAR DRUG DELIVERY 27
TABLE 16 DRUG DELIVERY TECHNOLOGY MARKET BY SOLID OCULAR DRUG DELIVERY 28
TABLE 17 DRUG DELIVERY TECHNOLOGY MARKET BY SEMI-SOLID OCULAR DRUG DELIVERY. 28
TABLE 18 GLOBAL DRUG DELIVERY TECHNOLOGY MARKET BY NASAL DRUG DELIVERY 28
TABLE 19 GLOBAL DRUG DELIVERY TECHNOLOGY MARKET BY NASAL DROPS DELIVERY 28
TABLE 20 GLOBAL DRUG DELIVERY TECHNOLOGY MARKET BY NASAL SPRAYS DELIVERY 28
TABLE 21 GLOBAL DRUG DELIVERY TECHNOLOGY MARKET BY NASAL POWDERS DELIVERY 28
TABLE 22 GLOBAL DRUG DELIVERY TECHNOLOGY MARKET BY NASAL GELS DELIVERY 28
TABLE 23 GLOBAL DRUG DELIVERY TECHNOLOGY MARKET BY TOPICAL DRUG DELIVERY 28
TABLE 24 GLOBAL DRUG DELIVERY TECHNOLOGY MARKET BY LIQUID TOPICAL DRUG DELIVERY 28
TABLE 25 GLOBAL DRUG DELIVERY TECHNOLOGY MARKET BY SOLID TOPICAL DRUG DELIVERY 28
TABLE 26 GLOBAL DRUG DELIVERY TECHNOLOGY MARKET BY SEMI-SOLID TOPICAL DRUG DELIVERY 28
TABLE 27 GLOBAL DRUG DELIVERY TECHNOLOGY MARKET BY TRANSDERMAL TOPICAL DRUG DELIVERY 28
TABLE 28 GLOBAL DRUG DELIVERY TECHNOLOGY MARKET BY IMPLEMENTABLE DRUG DELIVERY 28
TABLE 29 GLOBAL DRUG DELIVERY TECHNOLOGY MARKET BY AQCTIVE IMPLEMENTABLE DRUG DELIVERY 28
TABLE 30 GLOBAL DRUG DELIVERY TECHNOLOGY MARKET BY PASSIVE IMPLEMENTABLE DRUG DELIVERY 28
TABLE 31 GLOBAL DRUG DELIVERY TECHNOLOGY MARKET BY TRANSMUCOSAL DRUG DELIVERY 28
TABLE 32 GLOBAL DRUG DELIVERY TECHNOLOGY MARKET BY ORAL TRANSMUCOSAL DRUG DELIVERY 28
TABLE 33 GLOBAL DRUG DELIVERY TECHNOLOGY MARKET BY OTHER TRANSMUCOSAL DRUG DELIVERY 29
TABLE 34 NORTH AMERICA POLYMERIC FOAMS TECHNOLOGIES MARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 29
TABLE 35 NORTH AMERICA POLYMERIC FOAMS TECHNOLOGIES MARKET ESTIMATES AND FORECAST BY REGION, 2012 – 2022 ($ BILLION) 29
TABLE 36 NORTH AMERICA POLYMERIC FOAMS TECHNOLOGIES MARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 29
TABLE 37 U.S. POLYMERIC FOAMS TECHNOLOGIES MARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 29
TABLE 38 U.S. POLYMERIC FOAMS TECHNOLOGIES MARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 29
TABLE 39 CANADA POLYMERIC FOAMS TECHNOLOGIES MARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 29
TABLE 40 CANADA POLYMERIC FOAMS TECHNOLOGIES MARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 –2022 ($ BILLION) 29
TABLE 41 CANADA POLYMERIC FOAMS TECHNOLOGIES MARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 29
TABLE 42 EUROPE POLYMERIC FOAMS TECHNOLOGIES MARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 29
TABLE 43 EUROPE POLYMERIC FOAMS TECHNOLOGIES MARKET ESTIMATES AND FORECAST BY REGION, 2012 – 2022 ($ BILLION) 29
TABLE 44 EUROPE POLYMERIC FOAMS TECHNOLOGIES MARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 29
TABLE 45 GERMANY POLYMERIC FOAMS TECHNOLOGIES MARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 29
TABLE 46 POLYMERIC FOAMS TECHNOLOGIES MARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 29
TABLE 47 UK POLYMERIC FOAMS TECHNOLOGIES MARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 29
TABLE 48 UK POLYMERIC FOAMS TECHNOLOGIES MARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 29
TABLE 49 ASIA PACIFIC POLYMERIC FOAMS TECHNOLOGIES MARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 29
TABLE 50 ASIA PACIFIC POLYMERIC FOAMS TECHNOLOGIES MARKET ESTIMATES AND FORECAST BY REGION, 2012 – 2022 ($ BILLION) 30
TABLE 51 ASIA PACIFIC POLYMERIC FOAMS TECHNOLOGIES MARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 30
TABLE 52 CHINA POLYMERIC FOAMS TECHNOLOGIES MARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 30
TABLE 53 CHINA POLYMERIC FOAMS TECHNOLOGIES MARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 30
TABLE 54 INDIA POLYMERIC FOAMS TECHNOLOGIES MARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 30
TABLE 55 INDIA POLYMERIC FOAMS TECHNOLOGIES MARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 30
TABLE 56 JAPAN POLYMERIC FOAMS TECHNOLOGIES MARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 30
TABLE 57 JAPAN POLYMERIC FOAMS TECHNOLOGIES MARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 30
TABLE 58 MIDDLE EAST & AFRICA POLYMERIC FOAMS TECHNOLOGIES MARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 30
TABLE 59 MIDDLE EAST & AFRICA POLYMERIC FOAMS TECHNOLOGIES MARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 30
TABLE 60 CENTRAL & SOUTH AMERICA POLYMERIC FOAMS TECHNOLOGIES MARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 30
TABLE 61 CENTRAL & SOUTH AMERICA POLYMERIC FOAMS TECHNOLOGIES MARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 30

FIGURE 1 MARKET SHARE BY REGIONS 31
FIGURE 2 UNITED STATES MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 31
FIGURE 3 CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 31
FIGURE 4 EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 31
FIGURE 5 GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 31
FIGURE 6 UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 31
FIGURE 7 FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 31
FIGURE 8 APAC MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 31
FIGURE 9 CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 31
FIGURE 10 INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 31
FIGURE 11 JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 31
FIGURE 12 MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 31
FIGURE 13 LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 32

Choose License


Contact Information

: 24/7 Research Support

: sales@briskinsights.com

: +448081890034 (UK)